A single hs-CRP is a weak estimate of your baseline
What These Measurements Mean Together
hs-CRP exhibits substantial within-person biological variability over time. A systematic review and meta-analysis of 60 studies found a median within-subject coefficient of variation of 44% (range 27–76%) for hs-CRP and 41% for standard CRP (range 11–89%). The authors caution that these estimates rest on small numbers of participants and repeated measurements. Consequently, a single blood draw only loosely places an individual within risk strata. A retrospective cohort of 472,811 primary-care patients — the largest analysis of CRP variation to date — reported an overall within-individual coefficient of variation of 1.604 (95% CI 1.602–1.606), far above the 0.41 median of earlier studies (Gough et al., 2025, PMID 41284612). Consensus medical guidelines explicitly recommend averaging two separate measurements taken at least two weeks apart in metabolically stable patients before establishing baseline cardiovascular risk.
What This Does NOT Mean
What these results cannot tell you:
- × That hs-CRP is an unreliable clinical biomarker — it means a single spot check is being asked to do more than biological noise permits.
- × That a single normal reading guarantees absence of inflammation, or that a single reading of 2.9 mg/L represents persistent risk.
What to Consider & Next Steps
Obtain two separate measurements at least two weeks apart, drawn during metabolically stable periods without acute illness or strenuous exertion, and average the two values before drawing conclusions.
Frequently Asked Questions
What does this pattern mean when evaluating blood test results?
hs-CRP exhibits substantial within-person biological variability over time. A systematic review and meta-analysis of 60 studies found a median within-subject coefficient of variation of 44% (range 27–76%) for hs-CRP and 41% for standard CRP (range 11–89%). The authors caution that these estimates rest on small numbers of participants and repeated measurements. Consequently, a single blood draw only loosely places an individual within risk strata. A retrospective cohort of 472,811 primary-care patients — the largest analysis of CRP variation to date — reported an overall within-individual coefficient of variation of 1.604 (95% CI 1.602–1.606), far above the 0.41 median of earlier studies (Gough et al., 2025, PMID 41284612). Consensus medical guidelines explicitly recommend averaging two separate measurements taken at least two weeks apart in metabolically stable patients before establishing baseline cardiovascular risk.
What should this pattern NOT be used to infer?
That hs-CRP is an unreliable clinical biomarker — it means a single spot check is being asked to do more than biological noise permits. That a single normal reading guarantees absence of inflammation, or that a single reading of 2.9 mg/L represents persistent risk.
What is the recommended retesting frequency, and what should you consider next?
Obtain two separate measurements at least two weeks apart, drawn during metabolically stable periods without acute illness or strenuous exertion, and average the two values before drawing conclusions.
Summary
- Interpretation Rule
- Interprets Panel, Not Person
Scientific Citations (3)
- [1] Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. Circulation. 2003;107(3):499-511.
"Measurement of markers should be done twice (averaging results), optimally two weeks apart, fasting or nonfasting in metabolically stable patients... two separate measurements of hs-CRP are adequate to classify a person's risk level and to account for the increased within-individual variability."
- [2] Gough A, Sitch A, Ferris E, Marshall T. Within-subject variation of C-reactive protein and high-sensitivity C-reactive protein: a systematic review and meta-analysis. PLoS One. 2024;19(11):e0304961.
- [3] Gough A, Sitch A, Marshall T. Within-individual variation of C-reactive protein (CRP) measurements in primary care: A retrospective cohort study. PLoS One. 2025;20(11):e0337221.
Related Patterns
Track Your Inflammation — Cohort Now Forming
Track your own inflammatory gene expression over time. Reserve your spot in the Inflammation Compass founding cohort today to lock in early pricing before the general public.